Creating smarter ways to fight bacteria
Leading the advancement of technologies and products
that break up biofilms and destroy bacteria.
R+D
For over 10 years Kane Biotech’s R+D division has been developing new technologies and innovations leading to 75 patents and patents pending in biotechnology focusing primarily on biofilm.
75
1
Patents and Patents Pending
Human Health
Biofilms are estimated to be responsible for 80% of all human bacterial infections, costing billions of dollars each year.
Animal Health
The companion pet market in North America has grown to an estimated $62 billion in sales per year, with the oral health care segment growing rapidly at approximately 20%.
Industrial
The rapidly expanding industry for biomedical devices is estimated at $180 billion, yet it continues to suffer from microbial colonization. Microbial infections can develop on all medical devices and hard surfaces.